Ålandsbanken
Bank of Åland Plc
Other information disclosed according to the rules of the Exchange
February 24, 2021, 4.15 p.m
Notification of an application for the admission of a security to trading in a regulated market
The Bank of Åland Plc has filed an application to Nasdaq Helsinki Ltd for the admission of the below-mentioned securities (EUR denominated covered bond issue) to trading in a regulated market.
Name of issue: Ålandsbanken EUR 200,000,000 Covered Bonds due 2024
ISIN code: FI4000490677
Issue amount: EUR 200 000 000
The Final Terms of the Issue are available at the issuer’s website:
https://www.alandsbanken.com/about-us/debt-investors/debt-programme
For further information, please contact:
Peter Wiklöf, Managing Director and Chief Executive, phone +358 40 512 7505
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
CNH Industrial N.V.9.11.2025 09:00:00 CET | Press release
CNH introduces FLEETPRO aftermarket line-up at Agritechnica 2025
Ecorobotix SA8.11.2025 12:15:00 CET | Press release
Ecorobotix Showcases World-First AI Capability for Safe, Targeted Use of Non-Selective Contact Herbicides at Agritechnica
IOT Squared8.11.2025 11:00:00 CET | Press release
Saudi “Emerge” Emergency and Crisis Resilience Platform Named Among the World’s Best Smart City Solutions in the 2025 Smart City Awards
Novo Nordisk A/S8.11.2025 09:18:56 CET | Press release
Novo Nordisk will not increase its proposal to acquire Metsera, Inc.
Teva Pharmaceutical Industries Ltd8.11.2025 00:00:00 CET | Press release
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
